AZ Targets Viral Oncolytics With Transgene Development Deal

 
• By Jo Shorthouse
  
LightBulbs
AZ will provide five molecules for development • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip